Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia (original) (raw)
Unger, S.L. et al. Multiple epiphyseal dysplasia: radiographic abnormalities correlated with genotype. Pediatr. Radiol.31, 10–18 (2001). ArticleCAS Google Scholar
Haga, N. et al. Stature and severity in multiple epiphyseal dysplasia. J. Pediatr. Orthop.18, 394–397 (1998). CASPubMed Google Scholar
Treble, N.J., Jensen, F.O., Bankier, A., Rogers, J.G. & Cole, W.G. Development of the hip in multiple epiphyseal dysplasia. Natural history and susceptibility to premature osteoarthritis. J. Bone Joint Surg.72, 1061–1064 (1990). ArticleCAS Google Scholar
Briggs, M.D. et al. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nature Genet.10, 330–336 (1995). ArticleCAS Google Scholar
Briggs, M.D. et al. Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum. Am. J. Hum. Genet.62, 311–319 (1998). ArticleCAS Google Scholar
Muragaki, Y. et al. A mutation in the gene encoding the alpha 2 chain of the fibril- associated collagen IX, COL9A2, causes multiple epiphyseal dysplasia (EDM2). Nature Genet.12, 103–105 (1996). ArticleCAS Google Scholar
Holden, P. et al. Identification of novel pro-alpha2(IX) collagen gene mutations in two families with distinctive oligoepiphyseal forms of multiple epiphyseal dysplasia. Am. J. Hum. Genet.65, 31–38 (1999). ArticleCAS Google Scholar
Bonnemann, C.G. et al. A mutation in the alpha 3 chain of type IX collagen causes autosomal dominant multiple epiphyseal dysplasia with mild myopathy. Proc. Natl. Acad. Sci. USA97, 1212–1217 (2000). ArticleCAS Google Scholar
Lohiniva, J. et al. Splicing mutations in the COL3 domain of collagen IX cause multiple epiphyseal dysplasia. Am. J. Med. Genet.90, 216–222 (2000). ArticleCAS Google Scholar
Spayde, E.C. et al. Exon skipping mutation in the COL9A2 gene in a family with multiple epiphyseal dysplasia. Matrix Biol.19, 121–128 (2000). ArticleCAS Google Scholar
Deere, M., Sanford, T., Francomano, C.A., Daniels, K. & Hecht, J.T. Identification of nine novel mutations in cartilage oligomeric matrix protein in patients with pseudoachondroplasia and multiple epiphyseal dysplasia. Am. J. Med. Genet.85, 486–490 (1999). ArticleCAS Google Scholar
Loughlin, J. et al. Identification of five novel mutations in cartilage oligomeric matrix protein gene in pseudoachondroplasia and multiple epiphyseal dysplasia Hum. Mutat. Suppl. S10–S17 (1998).
Ikegawa, S. et al. Novel and recurrent COMP (cartilage oligomeric matrix protein) mutations in pseudoachondroplasia and multiple epiphyseal dysplasia. Hum. Genet.103, 633–638 (1998). ArticleCAS Google Scholar
Holden, P. et al. Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family. J. Biol. Chem.276, 6046–6055 (2001). ArticleCAS Google Scholar
Thur, J. et al. Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen I, II, and IX. J. Biol. Chem.276, 6083–6092 (2001). ArticleCAS Google Scholar
Superti-Furga, A. et al. Recessively inherited multiple epiphyseal dysplasia with normal stature, club foot, and double layered patella caused by a DTDST mutation. J. Med. Genet.36, 621–624 (1999). CASPubMedPubMed Central Google Scholar
Mortier, G.R., Chapman, K.L., Leroy, J.L. & Briggs, M.D. Clinical and radiographic features of multiple epiphyseal dysplasia not linked to the COMP or type IX collagen genes. Eur. J. Hum. Genet. (in the press).
Belluoccio, D., Schenker, T., Baici, A. & Trueb, B. Characterization of human matrilin-3 (MATN3). Genomics53, 391–394 (1998). ArticleCAS Google Scholar
Wagener, R. et al. Structure and mapping of the mouse matrilin-3 gene (Matn3), a member of a gene family containing a U12-type AT-AC intron. Mamm. Genome11, 85–90 (2000). ArticleCAS Google Scholar
Chen, Q., Zhang, Y., Johnson, D.M. & Goetinck, P.F. Assembly of a novel cartilage matrix protein filamentous network: molecular basis of differential requirement of von Willebrand factor A domains. Mol. Biol. Cell10, 2149–2162 (1999). ArticleCAS Google Scholar
Aszodi, A. et al. Normal skeletal development of mice lacking matrilin 1: redundant function of matrilins in cartilage? Mol. Cell. Biol.19, 7841–7845 (1999). ArticleCAS Google Scholar
Maddox, B.K. et al. The fate of cartilage oligomeric matrix protein is determined by the cell type in the case of a novel mutation in pseudoachondroplasia. J. Biol. Chem.272, 30993–30997 (1997). ArticleCAS Google Scholar
Delot, E., Brodie, S.G., King, L.M., Wilcox, W.R. & Cohn, D.H. Physiological and pathological secretion of cartilage oligomeric matrix protein by cells in culture. J. Biol. Chem.273, 26692–26697 (1998). ArticleCAS Google Scholar
Hecht, J.T. et al. Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachondroplasia musculoskeletal tissues. Matrix Biol.17, 269–278 (1998). ArticleCAS Google Scholar
Hecht, J.T. et al. Retention of cartilage oligomeric matrix protein (COMP) and cell death in redifferentiated pseudoachondroplasia chondrocytes. Matrix Biol.17, 625–633 (1998). ArticleCAS Google Scholar
Sasaki, T. et al. A Bethlem myopathy Gly to Glu mutation in the von Willebrand factor A domain N2 of the collagen alpha3(VI) chain interferes with protein folding. FASEB J.14, 761–768 (2000). ArticleCAS Google Scholar
International Working Group on Constitutional Diseases of Bone. International nomenclature and classification of the osteochondrodysplasias (1997). Am. J. Med. Genet.79, 376–382 (1998).
Briggs, M.D. Screening for mutations in cartilage ECM genes. Methods Mol. Biol.139, 133–145 (2000). CASPubMed Google Scholar